Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Bilihome logo — wearable jaundice therapy for natural newborn care

Bilihome

wearable jaundice therapy for natural newborn care

Founded 2019 The Netherlands The Netherlands 8 employees Seed Total: $340.00K Care Economy, Fashion +3

General Information

Company Name Bilihome
Founded Year 2019
Location The Netherlands The Netherlands
Employees 8
Industries Care Economy, Fashion, Health Care +2
Funding Stage Seed
Business Model B2B, D2C, B2C
Revenue Model Product Sales, Leasing/Rental, Service Fee
Offices as of Oct 2026
Nijkerk, The Netherlands Eindhoven, The Netherlands Arnhem, The Netherlands
Social

BounceWatch is an independent company data service, not affiliated with Bilihome. To contact Bilihome, visit bilihome.org.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bilihome compare?

A PDF of Bilihome and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bilihome soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 30, 2026

Bilihome is nominated for MedTech Innovation of the Year at MedTech World Europe 2026.

Regulatory Approval Oct 18, 2026

Bilihome received regulatory approval for its wearable phototherapy solution, which fundamentally differs from conventional systems, facilitating its entry into the market.

Bilihome a competitor of yours? Have our desk watch it

About Bilihome

Bilihome, founded in 2019 in The Netherlands, is revolutionizing neonatal care with its innovative product: a wearable jaundice therapy device designed for natural newborn care. The brainchild of a concerned parent, this company emerged from a personal quest to improve postnatal outcomes by enabling phototherapy treatment at home.

Operating at the intersection of Care Economy, Fashion, Health Care, Health and Wellness, and Medical Devices, Bilihome is redefining neonatal health protocols. Their intuitive solution offers convenience and efficiency, minimizing extended hospital stays and associated stress for new families.

Supported by NLC – The European Healthtech Venture Builder, Bilihome recently secured a €140.00K seed investment from Health Venture as of 01 June 2024. This funding underscores the growing confidence in the company's potential to significantly impact newborn care globally.

Business keywords: wearable technology, neonatal care, jaundice treatment, home healthcare, phototherapy, smart wearables, newborn health, value-based care, family-centered care, medtech innovation, remote patient monitoring, hospital-to-home transition, pediatric health, NICU alternative

Services & Products

Wearable Phototherapy Solution
Blue Light Therapy Integration
Home and Hospital Treatment for Jaundice

Target Customers

Hospitals Healthcare Professionals Parents of Newborns

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed €140.00K 1
Health Venture
Health Venture
01 Jun 2024
Early VC Undisclosed 2
Oost NL Health Innovations
Oost NL, Health Innovations
01 Jan 2022
Seed €200.00K 1
Health Venture
Health Venture
01 Feb 2020
Seed Undisclosed 1
Health Venture
Health Venture
01 Jun 2019

Bilihome Alternatives & Competitors

View All Alternatives
Bilihome vs
Tiny Hearts Technology
Tiny Hearts Technology Nigeria

Revolutionalizing maternal and infant healthcare in communities across Sub Saharan Africa.

Grant
5 employees
Health Care, Medical Devices
Bilihome vs
NeoLight, LLC
NeoLight, LLC United States

A company focused on empathy driven innovation

Venture round
46 employees
Health Care, Health and Wellness
Bilihome vs
Vitara Biomedical
Vitara Biomedical United States

Because every day counts

Series B
65 employees
Care Economy, Health Care
Compare Bilihome vs Vitara Biomedical
Also compare with: Bilihome vs Philips Philips View all alternatives

FAQ About Bilihome

wearable jaundice therapy for natural newborn care
Bilihome was founded in 2019.
Bilihome is headquartered in The Netherlands. As of Oct 2026, it also has offices in Nijkerk, The Netherlands, Eindhoven, The Netherlands and Arnhem, The Netherlands.
Bilihome operates in Care Economy, Fashion, Health Care, Health and Wellness and Medical Devices. Its work centres on wearable technology, neonatal care, jaundice treatment and home healthcare. Its customers include Hospitals, Healthcare Professionals and Parents of Newborns.
Bilihome has a B2B, D2C and B2C business model. Its revenue comes from Product Sales, Leasing/Rental and Service Fee.
Bilihome has approximately 8 employees.
Bilihome has completed 4 funding rounds, raising a total of $340.00K. The latest funding stage is Seed.
Bilihome offers: Wearable Phototherapy Solution, Blue Light Therapy Integration, Home and Hospital Treatment for Jaundice.
Top alternatives and competitors to Bilihome include Tiny Hearts Technology, NeoLight, LLC, Vitara Biomedical, Heamac Healthcare Pvt Ltd, Cardiomo. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bilihome and Tiny Hearts Technology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bilihome, https://bouncewatch.com/company/bilihome-bv, updated 10 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout